Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Anne, Farret"'
Autor:
Pierre-Yves Benhamou, ProfMD, Sylvia Franc, MD, Yves Reznik, ProfMD, Charles Thivolet, ProfMD, Pauline Schaepelynck, MD, Eric Renard, ProfMD, Bruno Guerci, ProfMD, Lucy Chaillous, MD, Celine Lukas-Croisier, MD, Nathalie Jeandidier, ProfMD, Helene Hanaire, ProfMD, Sophie Borot, MD, Maeva Doron, Pierre Jallon, Ilham Xhaard, PhD, Vincent Melki, MD, Laurent Meyer, MD, Brigitte Delemer, ProfMD, Marie Guillouche, MD, Laurene Schoumacker-Ley, MD, Anne Farret, MD, Denis Raccah, ProfMD, Sandrine Lablanche, MD, Michael Joubert, ProfMD, Alfred Penfornis, ProfMD, Guillaume Charpentier, MD
Publikováno v:
The Lancet: Digital Health, Vol 1, Iss 1, Pp e17-e25 (2019)
Summary: Background: Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system impro
Externí odkaz:
https://doaj.org/article/bf42d9c4d29145c98bb3dcf6ec9f667f
Autor:
E. Bismuth, Sabine Rudoni, Pauline Schaepelynck, Sophie Borot, A. Sola-Gazagnes, B. Catargi, Bruno Guerci, E. Bonnemaison, Clémence Fradet, Michael Joubert, J. Guillemot, A. Penfornis, Didier Gouet, Jean-Pierre Riveline, Hélène Hanaire, Anne Farret
Publikováno v:
Médecine des Maladies Métaboliques. 14:608-616
Resume Les donnees concernant les alarmes des dispositifs de mesure continue du glucose sont peu nombreuses dans la litterature. L’objectif de cette etude etait d’obtenir un consensus sur les avantages et inconvenients des alarmes de seuil de glu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::434199a84a32b1bd366277916ac878bc
https://doi.org/10.1016/j.mmm.2020.08.003
https://doi.org/10.1016/j.mmm.2020.08.003
Autor:
Denis Raccah, Pauline Schaepelynck, Marie Guillouche, Laurène Schoumacker-Ley, Michael Joubert, Hélène Hanaire, Sophie Borot, Alfred Penfornis, V. Melki, Guillaume Charpentier, Brigitte Delemer, Eric Renard, Pierre Jallon, Maeva Doron, Pierre-Yves Benhamou, Nathalie Jeandidier, Laurent Meyer, Sandrine Lablanche, Charles Thivolet, I. Xhaard, Bruno Guerci, Yves Reznik, Sylvia Franc, Anne Farret, Céline Lukas-Croisier, Lucy Chaillous
Publikováno v:
The Lancet Digital Health
The Lancet Digital Health, 2019, 1 (1), pp.e17-e25. ⟨10.1016/S2589-7500(19)30003-2⟩
The Lancet: Digital Health, Vol 1, Iss 1, Pp e17-e25 (2019)
The Lancet Digital Health, 2019, 1 (1), pp.e17-e25. ⟨10.1016/S2589-7500(19)30003-2⟩
The Lancet: Digital Health, Vol 1, Iss 1, Pp e17-e25 (2019)
Summary: Background: Closed-loop insulin delivery systems are expected to become a standard treatment for patients with type 1 diabetes. We aimed to assess whether the Diabeloop Generation 1 (DBLG1) hybrid closed-loop artificial pancreas system impro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b70efd1ce60a721ac0f6a63a3957a801
https://doi.org/10.1016/s2589-7500(19)30003-2
https://doi.org/10.1016/s2589-7500(19)30003-2
Autor:
Bogdan Catargi, Guillaume Charpentier, Pauline Schaepelynck, Michael Joubert, Bruno Guerci, Pierre Fontaine, Hélène Hanaire, Bruno Detournay, Anne Farret, Pierre Simon, Lucy Chaillous, Eric Bavière, Nathalie Jeandidier, Yves Reznik, Alfred Penfornis, Yacine Kherbachi, Sylvia Franc, P. Serusclat, Pierre-Yves Benhamou, Sophie Borot
Publikováno v:
Journal of diabetes science and technology
Journal of diabetes science and technology, Diabetes Technology Society, 2019, pp.193229681983405
Journal of diabetes science and technology, Diabetes Technology Society, 2019, pp.193229681983405. ⟨10.1177/1932296819834054⟩
Journal of diabetes science and technology, Diabetes Technology Society, 2019, pp.193229681983405
Journal of diabetes science and technology, Diabetes Technology Society, 2019, pp.193229681983405. ⟨10.1177/1932296819834054⟩
Benefits of telemedicine have been proven in the field of diabetes. Among a number of technical solutions, Diabeo® has been studied in both type 1 and type 2 diabetes with intensive insulin therapy. This digital therapeutic system contains a self-mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22e331be6a904d19b4c4d95d691ec79e
https://doi.org/10.1177/1932296819834054
https://doi.org/10.1177/1932296819834054
Autor:
Sylvia Franc, N Filhol, Yves Reznik, Pierre-Yves Benhamou, Jerome Place, C Guillot, Pauline Schaepelynck, A Desserprix, Anne Farret, E. Bonnemaison, Sophie Borot, Eric Renard, B. Delemer, D Durain, P. Serusclat, Marion Munch, Lucy Chaillous, Isabelle Guilhem, A. Penfornis, A. Sola-Gazagnes, N. Tubiana-Rufi, Sfd Sfd Paramedical Sfe Sfedp Ajd Ffd Fenarediam, Guillaume Charpentier, Jacques Beltrand, R. Leroy, Michael Joubert, Cnp-Edn, Bruno Guerci, Jean-Pierre Riveline, V. Melki, S Picard, C Abettan, C. Thivolet, Sandrine Lablanche, Hélène Hanaire, E. Bismuth, Nathalie Jeandidier
Publikováno v:
Diabetes and Metabolism
Diabetes and Metabolism, Elsevier Masson, 2021, 47 (3), pp.101206. ⟨10.1016/j.diabet.2020.10.004⟩
Diabetes & Metabolism
Diabetes & Metabolism, 2021, 47 (3), pp.101206. ⟨10.1016/j.diabet.2020.10.004⟩
Diabetes and Metabolism, Elsevier Masson, 2021, 47 (3), pp.101206. ⟨10.1016/j.diabet.2020.10.004⟩
Diabetes & Metabolism
Diabetes & Metabolism, 2021, 47 (3), pp.101206. ⟨10.1016/j.diabet.2020.10.004⟩
International audience; Automated closed-loop (CL) insulin therapy has come of age. This major technological advance is expected to significantly improve the quality of care for adults, adolescents and children with type 1 diabetes. To improve access
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53c2a286638b450215d247a5f42b92ce
https://hal.umontpellier.fr/hal-03269986
https://hal.umontpellier.fr/hal-03269986
Autor:
Yves Reznik, Pierre Fontaine, Anne Farret, Lucy Chaillous, Pierre Serusclat, Geneviève d’Orsay, Bogdan Catargi, Sylvia Franc, Sophie Borot, Pierre Simon, Pauline Schaepelynck, Yacine Kherbachi, Bruno Guerci, Bruno Detournay, Nathalie Jeandidier, Alfred Penfornis, Guillaume Charpentier, Hélène Hanaire, Pierre-Yves Benhamou
Publikováno v:
Diabetes Technology & Therapeutics
Background: The DIABEO® system (DS) is a telemedicine solution that combines a mobile app for patients with a web portal for health care providers. DS allows real-time monitoring of basal-bolus insulin therapy as well as therapeutic decision-making,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::572701eb3c52d1607be67f229c94c611
https://pubmed.ncbi.nlm.nih.gov/32407148
https://pubmed.ncbi.nlm.nih.gov/32407148
Autor:
P.Y. Benhamou, G. Charpentier, Sylvia Franc, Bruno Guerci, Pauline Schaepelynck, B. Catargi, A. Penfornis, E. Bonnemaison, N. Tubiana, Nathalie Jeandidier, Isabelle Guilhem, Didier Gouet, N Filhol, Eric Renard, C. Guillot, Yves Reznik, C. Atlan, E. Bismuth, V. Melki, Sabine Rudoni, E. Merlen, Michael Joubert, A. Sola-Gazagnes, Anne Farret, Sophie Borot, S Picard, J.P. Riveline, Hélène Hanaire, O. Verier-Mine
Publikováno v:
Médecine des Maladies Métaboliques. 11:S1-S37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d992bb870463a9c2f6434c7054e5bef0
https://doi.org/10.1016/s1957-2557(18)30030-0
https://doi.org/10.1016/s1957-2557(18)30030-0
From the initial bedside in-hospital artificial pancreas (AP), the development of wearable ambulatory closed-loop systems for the therapy of type 1 diabetes has prioritized the mode of subcutaneous (SC) insulin delivery according to the widespread di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8b97e1635923eeb7ff539bc1762d4056
https://doi.org/10.1016/b978-0-12-815655-1.00014-4
https://doi.org/10.1016/b978-0-12-815655-1.00014-4
Autor:
Stacey M. Anderson, Ananda Basu, Rita Basu, Fernando Bianchi, Jorge Bondia, Rachel Brandt, Marc D. Breton, Sue A. Brown, Ankush Chakrabarty, Daniel R. Cherñavvsky, Ali Cinar, Claudio Cobelli, Patricio Colmegna, Chiara Dalla Man, Eyal Dassau, Hernán De Battista, Mark DeBoer, Simone Del Favero, Sunil Deshpande, Francis J. Doyle, Anne Farret, Gregory P. Forlenza, Fabricio Garelli, Iman Hajizadeh, Nicole Hobbs, Boris P. Kovatchev, David M. Maahs, Lalo Magni, Laurel H. Messer, Stephen D. Patek, Jerôme Place, Mudassir Rashid, Eric Renard, Sediqeh Samadi, Ricardo S. Sánchez-Peña, Michele Schiavon, Mert Sevil, Dawei Shi, Tara Sowrirajan, Chiara Toffanin, Josep Vehí, Roberto Visentin, Stamatina Zavitsanou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::260b5daeda6662cef55f5a7e8483de89
https://doi.org/10.1016/b978-0-12-815655-1.00006-5
https://doi.org/10.1016/b978-0-12-815655-1.00006-5
Publikováno v:
La Revue de l'Infirmière. 66:35-37
Almost 45 000 patients with type 1 diabetes are concerned in France by outpatient insulin pump therapy. The first systems of insulin pump therapy guided by glycaemia have evolved driven by the work carried out by multi-disciplinary research teams. To
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05eef3f85ad1ca639d9bde114d39ab25
https://doi.org/10.1016/j.revinf.2017.02.010
https://doi.org/10.1016/j.revinf.2017.02.010